Page last updated: 2024-09-04

docetaxel anhydrous and dofequidar

docetaxel anhydrous has been researched along with dofequidar in 2 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(dofequidar)
Trials
(dofequidar)
Recent Studies (post-2010) (dofequidar)
12,1103,2166,9204025

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirata, H; Matsuba, Y; Naito, M; Sato, S; Tsuruo, T1
Bonneterre, J; Bonneterre, ME; Degardin, M; Diéras, V; Fumoleau, P; Lacombe, D; Laurence, V; Marreaud, S; Pierga, JY1

Trials

1 trial(s) available for docetaxel anhydrous and dofequidar

ArticleYear
Phase I combining a P-glycoprotein inhibitor, MS209, in combination with docetaxel in patients with advanced malignancies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Sep-01, Volume: 11, Issue:17

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Prospective Studies; Quinolines; Taxoids; Treatment Outcome

2005

Other Studies

1 other study(ies) available for docetaxel anhydrous and dofequidar

ArticleYear
MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle; Cell Division; Cell Line; Docetaxel; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Inhibitory Concentration 50; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mitosis; Models, Chemical; Neoplasm Transplantation; Paclitaxel; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Time Factors; Tumor Cells, Cultured

2002
chemdatabank.com